Yes. I think a lot of people trading in the Australian/New Zealand market simply don't understand what a Phase 3-ready drug like this is worth. Honestly I think many are clueless.
This company trades at a $30 million USD market cap right now. I am not kidding, that is a monumental, almost unimaginable, undervaluation. I can't express this enough. The company is worth 10 times that on the low side. Let's see, the only preventative food and waterborne GI-illness drug, DoD thinks it may be the key to a Shigella vaccine (evidence backs this up), every person without exception believes Traelan is extraordinarily effective, (sales increasing 150% YoY in USA and just started), Arun Sanyal thinks IMM-124E has a huge role to play in treating NASH, so does NIH (two 100% funded PNAFLD & ASH Phase 2 trials), a Phase 2 C.Diff. readout coming our way, goes on and on and on.
The company and its 3.53 million shares is worth between $100-$300 USD. I said it. Think what you may. Let's see how this plays out.
- Forums
- ASX - By Stock
- IMC
- Big Pharma Partnership
Big Pharma Partnership, page-4
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.002(2.02%) |
Mkt cap ! $22.11M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.7¢ | $10.38K | 105K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 20229 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.097 |
1 | 51371 | 0.096 |
2 | 114250 | 0.095 |
1 | 100000 | 0.094 |
2 | 91731 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 20229 | 1 |
0.100 | 157482 | 3 |
0.105 | 295769 | 3 |
0.110 | 96204 | 3 |
0.120 | 138000 | 3 |
Last trade - 13.42pm 18/09/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |